| Literature DB >> 22168953 |
Mizuki Morita1, Avsk Mohan Katta, Shandar Ahmad, Takaharu Mori, Yuji Sugita, Kenji Mizuguchi.
Abstract
BACKGROUND: Protein-lipid interactions play essential roles in the conformational stability and biological functions of membrane proteins. However, few of the previous computational studies have taken into account the atomic details of protein-lipid interactions explicitly.Entities:
Year: 2011 PMID: 22168953 PMCID: PMC3747235 DOI: 10.1186/2046-1682-4-21
Source DB: PubMed Journal: BMC Biophys ISSN: 2046-1682 Impact factor: 4.778
List of HET IDs for the phospholipids considered in this paper
| 2DP | 3PE | 3PH | 3PI | 4PT | 6PH | 6PL | 7PH | 8PE | 9PE |
| AGA | B7N | CDL | CDN | CN3 | CN5 | CN6 | CPL | DGG | DLP |
| DPG | DR9 | EPH | GP7 | HGP | HGX | HHG | HI5 | IP9 | L1P |
| L3P | L4P | L9Q | L9R | LAP | LHG | LIO | LOP | LP3 | LPC |
| LPE | LPP | LPS | LPX | MC3 | MYY | NKN | NKO | NKP | NKQ |
| NKR | OPC | OZ2 | P0E | P3A | P42 | P6L | PA6 | PBU | PC1 |
| PC2 | PC6 | PC7 | PC9 | PCF | PCK | PCW | PD7 | PDK | PEE |
| PEF | PEH | PEK | PEV | PEW | PFS | PGK | PGM | PGT | PGV |
| PGW | PIB | PIE | PIF | PII | PIO | PLC | PLD | PLX | POV |
| PS2 | PS6 | PSC | PSF | PT5 | PTY | PX4 | XPX | ||
List of transmembrane (TM) and non-transmembrane (non-TM) protein chains in complex with lipids
| Proteincodea | Protein name | Lipid codeb | Total contactsc | Chainlength |
|---|---|---|---|---|
| 1gzm_A | Rhodopsin | PEF | 5 | 329 |
| 1kqg_B | Formate dehydrogenase-N (Fdn-N) | CDL | 7 | 289 |
| 1kqg_C | Formate dehydrogenase-N (Fdn-N) | CDL | 5 | 216 |
| 1m56_D | Cytochrome c oxidase | PEH | 16 | 42 |
| 1nen_C | Succinate dehydrogenase (SQR) | CDN, EPH | 19 | 129 |
| 1nen_D | Succinate dehydrogenase (SQR) | CDN | 9 | 113 |
| 1pp9_Q | Cytochrome bc1 complex | CDL, PEE | 15 | 241 |
| 1pp9_T | Cytochrome bc1 complex | CDL, PEE | 12 | 76 |
| 1vf5_D | Cytochrome b6f complex | OPC | 5 | 168 |
| 1vf5_N | Cytochrome b6f complex | OPC | 6 | 202 |
| 1x0i_1 | Bacteriorhodopsin (BR) | L3P | 14 | 215 |
| 1xio_A | Sensory rhodopsin (SR) | PEE | 32 | 217 |
| 1zoy_D | Succinate:ubiquinone oxidoreductase (SQR) | EPH | 10 | 102 |
| 2b6o_A | Aquaporin-0 (AQP0) | MC3 | 27 | 235 |
| 2bl2_I | Vacuolar-type (V-type) sodium ion-pumping adenosine triphosphatase (Na+-ATPase) | LHG | 14 | 156 |
| 2brd_A | Bacteriorhodopsin (BR) | DPG | 47 | 222 |
| 2c3e_A | ADP/ATP translocase 1 | CDL | 40 | 293 |
| 2e75_B | Cytochrome b6f complex | OPC | 13 | 160 |
| 2e76_F | Cytochrome b6f complex | OPC | 5 | 32 |
| 2eau_A | Ca2+-ATPase | PTY | 19 | 994 |
| 2eim_W | Cytochrome c oxidase | CDL | 5 | 58 |
| 2ein_O | Cytochrome c oxidase | CDL, PEK, PSC | 18 | 226 |
| 2h89_C | Succinate:ubiquinone oxidoreductase (SQR) | PEE | 5 | 139 |
| 2hg3_H | Reaction center | CDL, PC9 | 14 | 240 |
| 2hh1_L | Reaction center | CDL, PC7, PC9 | 10 | 281 |
| 2hhk_M | Reaction center | CDL, PGK, PGT | 23 | 302 |
| 2irv_B | Rhomboid protease (GlpG) | PGV | 11 | 179 |
| 2r9r_B | Voltage-dependent K+ (Kv) channel | PGW | 35 | 386 |
| 2wll_B | Potassium Channel (Kir) | PLC | 6 | 266 |
| 2z73_B | Rhodopsin | PC1 | 5 | 347 |
| 3a7k_A | Halorhodopsin (HR) | L1P, L3P | 33 | 259 |
| 3abl_N | Cytochrome c oxidase | CDL, PEK, PGV, PSC | 29 | 513 |
| 3abl_P | Cytochrome c oxidase | CDL, PEK, PGV | 85 | 259 |
| 3abm_G | Cytochrome c oxidase | CDL, PEK, PGV | 25 | 83 |
| 3ag4_Z | Cytochrome c oxidase | PGV | 5 | 43 |
| 3bz2_A | Photosystem II (PSII) | LHG | 6 | 335 |
| 3bz2_C | Photosystem II (PSII) | LHG | 5 | 447 |
| 3bz2_D | Photosystem II (PSII) | LHG | 6 | 340 |
| 3cx5_C | Cytochrome bc1 complex | 6PH, 7PH, 8PE, 9PE, CN3, CN5 | 42 | 385 |
| 3ddl_B | Xanthorhodopsin (XR) | PCW, PX4 | 6 | 250 |
| 3eam_C | Bacterial ligand-gated ion channel homologue (GLIC) | PC1 | 23 | 311 |
| 3egw_C | Nitrate Reductase A (NarGHI) | AGA | 10 | 224 |
| 3emn_X | Voltage-dependent anion channel (VDAC) 1 | MC3 | 7 | 283 |
| 3h1j_R | Cytochrome bc1 complex | PEE, PLC | 11 | 196 |
| 3h1j_W | Cytochrome bc1 complex | PEE, PLC | 9 | 59 |
| 1bp1_A | Bactericidal/permeability-increasing protein (BPI) | PC1 | 47 | 456 |
| 1bwo_A | Nonspecific lipid transfer protein (ns-LTP1) | LPC | 20 | 90 |
| 1cqx_B | Flavohemoglobin | DGG | 15 | 403 |
| 1l8s_B | Phospholipase A2 (PLA2) | LPE | 11 | 124 |
| 1lsh_A | Lipovitellin (LV-1N, LV-1C) | PLD | 53 | 954 |
| 1lsh_B | Lipovitellin (LV-2) | PLD | 9 | 174 |
| 1s9a_B | 4-chlorocatechol 1 | HGP | 13 | 256 |
| 1tuk_A | Type 2 nonspecific lipid transfer protein (ns-LTP) | PGM | 11 | 67 |
| 1un8_A | Dihydroxyacetone kinase | MYY | 15 | 542 |
| 1y9t_A | Lipoprotein MxiM | HHG | 7 | 110 |
| 1yuc_B | Nuclear receptor liver receptor homolog 1 (LRH-1) | EPH | 22 | 240 |
| 2azq_A | Catechol 1 | PCF | 9 | 309 |
| 2e2x_B | Sec14 homology module of neurofibromin | PEV | 22 | 250 |
| 2obd_A | Cholesteryl ester transfer protein (CETP) | PCW | 41 | 472 |
| 2qgu_A | Phospholipid-binding protein | PEF | 12 | 179 |
| 2rak_A | PX-BAR membrane-remodeling unit of sorting nexin 9 (SNX9) | PIB | 5 | 382 |
| 2rkn_A | Defective in induced resistance 1 protein (DIR1) | LP3 | 22 | 77 |
| 2vwa_B | Soluble domain of up-regulated in infective sporozoites 3 (UIS3) | PTY | 12 | 100 |
| 2z0p_D | PH domain of Bruton's tyrosine kinase | 4PT | 13 | 161 |
| 2ze9_A | Phospholipase D | PD7 | 10 | 504 |
| 3a7c_A | Extracellular domain of Toll-like receptor 2 (TLR2) | PDK | 13 | 549 |
| 3bib_X | T cell immunoglobulin mucin protein 4 (TIM-4) | PSF | 9 | 109 |
| 3cx9_A | Human serum albumin (HSA) | LPX | 17 | 582 |
| 3e3c_B | Global regulator of LEE repressor (GrlR) | HHG | 15 | 118 |
| 3k7t_A | 6-hydroxy-L-nicotine oxidase | GP7 | 17 | 425 |
| 3mdb_C | Arf-GAP with dual PH domain-containing protein 1 | IP9 | 9 | 365 |
| 3mtx_B | Myeloid differentiation factor 1 (MD-1) | PGT | 18 | 140 |
a Protein ID and chain ID.
b HET IDs of all contacting lipids in the complex.
c Total number of residues with lipid contacts.
Figure 1Scatterplots of amino acid propensities for interacting with lipids derived from crystal structures and MD data. For (a) lipid head and (b) tail groups. The correlation coefficients were 0.81 and 0.95 for the head and tail groups, respectively.
Amino acid propensities for interacting with lipids from crystal structures and MD trajectories, and lipophilicity scales
| Propensity from crystal structuresa | Propensity from MD trajectories | Lipophilicity scaleb | ||||||
|---|---|---|---|---|---|---|---|---|
| Head group | Tail group | Head group | Tail group | POPC | octanol | |||
| TRP | 2.41 | (1.04) | 3.25 | (0.63) | 5.44 | 4.38 | -1.85 | -2.09 |
| PHE | 1.55 | (0.50) | 1.96 | (0.43) | 0.97 | 1.97 | -1.13 | -1.71 |
| TYR | 2.17 | (0.57) | 1.15 | (0.26) | 2.12 | 1.45 | -0.94 | -0.71 |
| LEU | 0.75 | (0.17) | 1.60 | (0.23) | 0.80 | 1.70 | -0.56 | -1.25 |
| ILE | 0.47 | (0.09) | 1.46 | (0.27) | 0.48 | 1.41 | -0.31 | -1.12 |
| CYS | 0.47 | (0.32) | 1.16 | (0.93) | 0.06 | 1.68 | -0.24 | -0.02 |
| MET | 0.96 | (0.25) | 1.47 | (0.38) | 1.01 | 1.56 | -0.23 | -0.67 |
| GLY | 0.53 | (0.20) | 0.43 | (0.13) | 0.42 | 0.42 | 0.01 | 1.15 |
| VAL | 0.60 | (0.18) | 1.24 | (0.41) | 0.40 | 1.23 | 0.07 | -0.46 |
| SER | 0.68 | (0.20) | 0.89 | (0.25) | 0.73 | 0.44 | 0.13 | 0.46 |
| THR | 0.82 | (0.25) | 0.76 | (0.15) | 0.43 | 0.35 | 0.14 | 0.25 |
| ALA | 0.54 | (0.15) | 0.92 | (0.19) | 0.22 | 0.66 | 0.17 | 0.50 |
| HIS | 1.99 | (0.39) | 0.53 | (0.09) | 1.35 | 0.88 | 0.17 | 0.11 |
| ASN | 1.92 | (0.47) | 0.43 | (0.13) | 1.57 | 0.31 | 0.42 | 0.85 |
| PRO | 0.56 | (0.37) | 0.35 | (0.12) | 0.77 | 0.65 | 0.45 | 0.14 |
| GLN | 1.69 | (0.98) | 0.51 | (0.26) | 1.26 | 0.25 | 0.58 | 0.77 |
| ARG | 2.42 | (0.65) | 0.27 | (0.21) | 3.85 | 0.43 | 0.81 | 1.81 |
| LYS | 1.64 | (0.58) | 0.23 | (0.09) | 3.26 | 0.55 | 0.99 | 2.80 |
| ASP | 0.51 | (0.32) | 0.06 | (0.04) | 0.61 | 0.00 | 1.23 | 3.64 |
| GLU | 0.56 | (0.57) | 0.30 | (0.13) | 0.93 | 0.12 | 2.02 | 3.63 |
The amino acids are sorted in the ascending order of the lipophilicity scale for POPC interface.
a Values in parentheses represent the estimated standard error of correlation. The average of the standard error is 0.41 for lipid head and 0.27 for tail groups.
b The oxidation state of HIS has been taken as neutral. All ARG and LYS are taken as positively and all ASP and GLU are taken as negatively charged.
Three-way relationships between the amino acid propensities for interacting with lipids from crystal structures and MD trajectories, and lipophilicity scales
| Propensity from crystal structures | Propensity from MD trajectories | Lipophilicity scalea | |||||
|---|---|---|---|---|---|---|---|
| Head group | Tail group | Head group | Tail group | POPC | octanol | ||
| 1.00 (0.00) | 0.19 (0.38) | 0.81 (0.06) | 0.32 (0.36) | -0.28 (0.27) | -0.16 (0.25) | ||
| 1.00 (0.00) | 0.33 (0.69) | 0.95 (0.05) | -0.87 (0.07) | -0.82 (0.05) | |||
| 1.00 (0.00) | 0.49 (0.66) | -0.24 (0.49) | -0.06 (0.40) | ||||
| 1.00 (0.00) | -0.84 (0.05) | -0.75 (0.07) | |||||
| 1.00 (0.00) | 0.92 (0.03) | ||||||
| 1.00 (0.00) | |||||||
All-against-all correlation coefficients between the properties presented in Table 3. Values in parentheses represent standard error in correlation (see Methods).
a The oxidation state of HIS has been taken as neutral. All ARG and LYS are taken as positively and all ASP and GLU are taken as negatively charged.
Figure 2Scatterplots of amino acid propensities for interacting with lipid tail groups versus the POPC lipophilicity scale. Propensities for lipid tail groups derived from (a) crystal structures and (b) MD data. The correlation coefficients were -0.87 and -0.84 for the propensities from crystal structures and MD data, respectively.
Lipid contact statistics in TM and non-TM proteins with (a) head group and (b) tail group atoms
| Transmembrane (TM) proteins | Non-transmembrane (non-TM) proteins | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Obsa | Expa | Counts | Signed chi-square | P-value | Obsa | Expa | Counts | Signed chi-square | P-value | |
| TRP†, ‡ | 3 | 2.23 | 84 | 0.27 | 6.06E-01 | |||||
| PHE†, ‡ | 13 | 9.06 | 341 | 1.72 | 1.90E-01 | |||||
| TYR†, ‡ | ||||||||||
| LEU | 28 | 37.40 | 1189 | -2.36 | 1.24E-01 | 20 | 21.85 | 823 | -0.16 | 6.92E-01 |
| ILE | 9 | 11.58 | 436 | -0.57 | 4.49E-01 | |||||
| CYS | 2 | 4.25 | 135 | -1.19 | 2.76E-01 | 2 | 4.51 | 170 | -1.40 | 2.37E-01 |
| MET | 11 | 11.51 | 366 | -0.02 | 8.80E-01 | 1 | 4.22 | 159 | -2.46 | 1.17E-01 |
| GLY‡ | 15 | 13.54 | 510 | 0.16 | 6.92E-01 | |||||
| VAL | 14 | 15.11 | 569 | -0.08 | 7.75E-01 | |||||
| SER | 14 | 20.57 | 654 | -2.10 | 1.47E-01 | 13 | 15.61 | 588 | -0.44 | 5.08E-01 |
| THR | 16 | 19.53 | 621 | -0.64 | 4.24E-01 | 5 | 10.62 | 400 | -2.98 | 8.45E-02 |
| ALA | 12 | 17.55 | 661 | -1.76 | 1.85E-01 | |||||
| HIS†, ‡ | 7 | 5.47 | 206 | 0.43 | 5.13E-01 | |||||
| ASN†, ‡ | 11 | 9.00 | 339 | 0.44 | 5.06E-01 | |||||
| PRO | 9 | 15.98 | 508 | -3.05 | 8.09E-02 | 6 | 10.36 | 390 | -1.83 | 1.76E-01 |
| GLN†, ‡ | 12 | 9.77 | 368 | 0.51 | 4.76E-01 | |||||
| ARG†, ‡ | ||||||||||
| LYS†, ‡ | 20 | 13.01 | 490 | 3.75 | 5.27E-02 | |||||
| ASP | 6 | 11.73 | 373 | -2.80 | 9.43E-02 | |||||
| GLU | 8 | 14.34 | 456 | -2.80 | 9.40E-02 | 7 | 13.04 | 491 | -2.80 | 9.45E-02 |
| TRP†, ‡ | ||||||||||
| PHE†, ‡ | ||||||||||
| TYR†, ‡ | 21 | 18.3 | 410 | 0.41 | 5.22E-01 | |||||
| LEU†, ‡ | ||||||||||
| ILE†, ‡ | ||||||||||
| CYS† | 7 | 6.0 | 135 | 0.16 | 6.88E-01 | 5 | 6.21 | 170 | -0.23 | 6.28E-01 |
| MET†, ‡ | 24 | 16.3 | 366 | 3.63 | 5.67E-02 | |||||
| GLY | ||||||||||
| VAL†, ‡ | 47 | 37.8 | 849 | 2.23 | 1.36E-01 | |||||
| SER | 26 | 29.1 | 654 | -0.34 | 5.61E-01 | |||||
| THR | 21 | 27.7 | 621 | -1.61 | 2.05E-01 | |||||
| ALA | 39 | 42.3 | 949 | -0.25 | 6.14E-01 | 24 | 24.14 | 661 | 0.00 | 9.78E-01 |
| HIS | 6 | 11.4 | 256 | -2.56 | 1.10E-01 | 3 | 7.52 | 206 | -2.72 | 9.92E-02 |
| ASN | ||||||||||
| PRO | 9 | 14.24 | 390 | -1.93 | 1.65E-01 | |||||
| GLN | 6 | 11.8 | 264 | -2.82 | 9.30E-02 | |||||
| ARG | 7 | 14.31 | 392 | -3.74 | 5.32E-02 | |||||
| LYS | ||||||||||
| ASP | ||||||||||
| GLU | ||||||||||
Statistically significant values (p-value <0.05 or 95% significance) are in bold font. The amino acids are sorted in the ascending order of the lipophilicity scale for POPC interface.
†, ‡ The dagger and double-dagger symbols are used to show residues in which observed contacts are more than expected for TM and non-TM proteins, respectively.
a Obs and Exp stand for observed and expected number of counts, respectively.